Cannabix Technologies Inc.

Equities

BLO

CA13765L1013

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange Other stock markets 15:59:59 2024-06-05 EDT			5-day change	1st Jan Change
0.66 ^CAD	0.00%		-16.46%	+266.67%

06-04	Cannabix Technologies Inc. announced that it has received CAD 0.6 million in funding	CI
05-23	Cannabix Technologies Inc. announced that it expects to receive CAD 0.6 million in funding	CI

Cannabix Technologies Inc. Reports Earnings Results for the First Quarter Ended July 31, 2022

September 21, 2022

Cannabix Technologies Inc. reported earnings results for the first quarter ended July 31, 2022. For the first quarter, the company reported net loss was CAD 0.555847 million compared to CAD 0.538197 million a year ago.

Latest news about Cannabix Technologies Inc.

Cannabix Technologies Inc. announced that it has received CAD 0.6 million in funding	06-03	CI
Cannabix Technologies Inc. announced that it expects to receive CAD 0.6 million in funding	05-22	CI
Cannabix Technologies Inc. Enters into Strategic Partnership and Development Agreement with Omega Laboratories Inc	05-16	CI
Cannabix Technologies and Omega Laboratories Inc. Enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology	05-16	CI
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa	05-07	CI
Cannabix Technologies Inc. to Deliver Breath Logix Alcohol Screening Device to Australia through Breathalyser Sales & Service Pty Ltd	04-30	CI
Friedel, LLC Deploys the Breath Logix Alcohol Breathalyzer from Cannabix Technologies Inc	04-25	CI
Cannabix Up 28% as it Says Breath Logix Alcohol Device Delivers "Positive Impact" to Private Monitoring Agency in Montana	04-25	MT
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands Product Series to Breath Logix	04-16	CI
Cannabix Technologies Inc. Appoints Phillip Olla to its Board of Directors	04-02	CI
Cannabix Technologies Inc. Announces Resignation of Kulwant Malhi as President and Director	03-29	CI
Cannabix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	03-18	CI
Cannabix Up Over 8% After Reporting Patent for Proprietary Laboratory Drug Analysis Device	01-03	MT
Cannabix Technologies Inc. Files Patent for Proprietary Laboratory Drug Analysis Device	01-03	CI
Cannabix Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	12-15	CI
Cannabix Technologies Inc. Completes Initial Electronics Testing on Contactless Alcohol Breathalyzer, Commences International Certification Plans	11-07	CI
Cannabix Technologies Inc. Reports its Mass Spectrometer Breath Sampler Technology Along with Breath Collection Unit Uses to Quantify Delta-9 THC Levels from Smoking and Edibles in Humans	23-10-03	CI
Cannabix Technologies Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-26	CI
Cannabix Technologies Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	23-08-24	CI
Cannabix Technologies Inc. Files Breath Sample Capture Patent and Detects Delta- 8 THC in Early Testing	23-08-04	CI
Cannabix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	23-03-29	CI
Cannabix Technologies' Breathalyzer Slated for Test Program at Montana Company	23-02-13	MT
Cannabix Technologies Inc. to Test Contactless Alcohol Breathalyzer in Montana	23-02-13	CI
Cannabix Technologies Inc. Enters into Memorandum of Understanding with the North Louisiana Criminalistics Laboratory	23-01-05	CI
Cannabix Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-12-21	CI

Chart Cannabix Technologies Inc.

Duration

Period

More charts

Company Profile

Cannabix Technologies Inc. is a Canada-based developer of marijuana and alcohol breath testing devices. The Companyâs primary business is the development of marijuana breathalyzer technology. It is developing technologies to detect Tetrahydrocannabinol (THC) in breath samples for law enforcement, employers and laboratories. In addition, it is developing non-contact alcohol screening devices targeted primarily for workplace settings. The MS Breath Sampler (MSBS) is specialized laboratory hardware developed by the Company to confirm THC in breath from humans. The MSBS is a method for collection of analytes of low volatility from human breath utilizing liquid secondary adsorption. Within the Breath Collection Unit (THC detection), the sample is captured inside a cartridge and loaded into the MSBS. In preliminary testing, the system has detected and confirmed THC in breath out to four hours after smoking with breath samples being stored and analyzed up to two days after sample collection.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-18 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
CANNABIX TECHNOLOGIES INC.	+266.67%	54.95M
THERMO FISHER SCIENTIFIC	+8.38%	220B
DANAHER CORPORATION	+15.78%	198B
BOSTON SCIENTIFIC CORPORATION	+31.27%	112B
SIEMENS HEALTHINEERS AG	+4.56%	66.17B
EDWARDS LIFESCIENCES CORPORATION	+14.19%	52.47B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.70%	50.77B
AGILENT TECHNOLOGIES, INC.	-3.93%	38.97B
GE HEALTHCARE TECHNOLOGIES INC.	-0.47%	35.13B
RESMED, INC.	+23.96%	31.32B

Other Advanced Medical Equipment & Technology